Harries A
IJTLD Open. 2025; 2(2):61-63.
PMID: 39959400
PMC: 11827671.
DOI: 10.5588/ijtldopen.24.0618.
Ragazan D, Povshedna T, Tognazzini S, Kaida A, Murray M, Cote H
AIDS Behav. 2025; .
PMID: 39890757
DOI: 10.1007/s10461-025-04644-8.
Rai M, Blazkova J, Kardava L, Justement J, Shi V, Manning M
Nat Med. 2025; 31(2):427-432.
PMID: 39753965
DOI: 10.1038/s41591-024-03357-0.
Zhang Y, Ji J, Zheng L, Cai M, Sun G, Ma Y
Front Immunol. 2024; 15:1452532.
PMID: 39735540
PMC: 11671397.
DOI: 10.3389/fimmu.2024.1452532.
Salvana E
Acta Med Philipp. 2024; 57(4):3-4.
PMID: 39618974
PMC: 11603096.
DOI: 10.47895/amp.v57i4.7864.
Guidelines for Antibiotics Prescription in Critically Ill Patients.
Khilnani G, Tiwari P, Mittal S, Kulkarni A, Chaudhry D, Zirpe K
Indian J Crit Care Med. 2024; 28(Suppl 2):S104-S216.
PMID: 39234229
PMC: 11369928.
DOI: 10.5005/jp-journals-10071-24677.
Gender and Age Trends in HIV Incidence in Turkey between 1990 and 2021: Joinpoint and Age-Period-Cohort Analyses.
Derin O
Medicina (Kaunas). 2024; 60(8).
PMID: 39202638
PMC: 11356638.
DOI: 10.3390/medicina60081357.
Developing a Theory-Based Instrument for Pre-Exposure Prophylaxis (PrEP) Uptake in People of Color Using a Qualitative Approach.
Raich S, Johansen C, Bhandari N, Batra K, Sharma M
Healthcare (Basel). 2024; 12(16.
PMID: 39201154
PMC: 11354126.
DOI: 10.3390/healthcare12161595.
Prognostic prediction models for treatment experienced people living with HIV: a protocol for systematic review and meta-analysis.
Wu X, Chen Y, Lu Z, Wang J, Zou H
BMJ Open. 2024; 14(8):e081129.
PMID: 39181549
PMC: 11344525.
DOI: 10.1136/bmjopen-2023-081129.
Assessment of Metabolic, Inflammatory, and Immunological Disorders Using a New Panel of Plasma Parameters in People Living with HIV Undergoing Antiretroviral Therapy-A Retrospective Study.
Szymanska B, Knysz B, Cieplucha H, Piwowar A
J Clin Med. 2024; 13(15).
PMID: 39124846
PMC: 11312710.
DOI: 10.3390/jcm13154580.
Psychosocial and mental health challenges facing perinatally HIV-infected adolescents along the Kenyan coast: a qualitative inquiry using the socioecological model.
Wanjala S, Nyongesa M, Luchters S, Abubakar A
Front Public Health. 2024; 12:1379262.
PMID: 39109160
PMC: 11300237.
DOI: 10.3389/fpubh.2024.1379262.
Design and optimization of piperidine-substituted thiophene[3,2-]pyrimidine-based HIV-1 NNRTIs with improved drug resistance and pharmacokinetic profiles.
Sun Y, Zhou Z, Shi Z, Zhao F, Xie M, Zhuo Z
Acta Pharm Sin B. 2024; 14(7):3110-3124.
PMID: 39027243
PMC: 11252457.
DOI: 10.1016/j.apsb.2024.03.021.
Antiviral Drug Discovery.
Zhou Z, Liu X, Kang D
Int J Mol Sci. 2024; 25(13).
PMID: 39000520
PMC: 11242367.
DOI: 10.3390/ijms25137413.
Vpr driving DNA methylation variation of CD4 + T cells in HIV-1 infection.
Wang P, Meng Z, Deng K, Gao Z, Cai J
Virol J. 2024; 21(1):97.
PMID: 38671522
PMC: 11046818.
DOI: 10.1186/s12985-024-02363-5.
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a....
Lancet. 2024; 403(10440):2133-2161.
PMID: 38642570
PMC: 11122111.
DOI: 10.1016/S0140-6736(24)00757-8.
Pathological proliferation: a potential mechanism for poor CD4 T cell recovery in people living with HIV.
Zhang Y, Ji J, Xie K, Cai M, Wang R, Zhang X
Front Cell Infect Microbiol. 2024; 14:1344778.
PMID: 38601742
PMC: 11004319.
DOI: 10.3389/fcimb.2024.1344778.
Determinants of an HIV Preventive Vaccine among a Highly Vulnerable Population: African American Men Who Have Sex with Men.
Xu M, Choi J, Rosenberger J, Zimmerman R, DiClemente R
Vaccines (Basel). 2024; 12(3).
PMID: 38543957
PMC: 10974539.
DOI: 10.3390/vaccines12030323.
Prioritizing Mental Health within HIV and Tuberculosis Services in PEPFAR.
Fukunaga R, Pierre P, Williams J, Briceno-Robaugh R, Kalibala S, Peterson M
Emerg Infect Dis. 2024; 30(4):1-5.
PMID: 38526190
PMC: 10977845.
DOI: 10.3201/eid3004.231726.
Structure-based design and optimization lead to the identification of novel dihydrothiopyrano[3,2-]pyrimidine derivatives as potent HIV-1 inhibitors against drug-resistant variants.
Wang Z, Zhang H, Gao Z, Sang Z, De Clercq E, Pannecouque C
Acta Pharm Sin B. 2024; 14(3):1257-1282.
PMID: 38486991
PMC: 10935503.
DOI: 10.1016/j.apsb.2023.11.023.
Leveraging big data for causal understanding in mental health: a research framework.
Newson J, Bala J, Giedd J, Maxwell B, Thiagarajan T
Front Psychiatry. 2024; 15:1337740.
PMID: 38439791
PMC: 10910083.
DOI: 10.3389/fpsyt.2024.1337740.
